- Home
- CMPX vs OPRT Comparison
CMPX vs OPRT Comparison
Compare CMPX & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- OPRT
- Stock Information
- Founded
- CMPX 2014
- OPRT 2005
- Country
- CMPX United States
- OPRT United States
- Employees
- CMPX N/A
- OPRT N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- OPRT Finance: Consumer Services
- Sector
- CMPX Health Care
- OPRT Finance
- Exchange
- CMPX Nasdaq
- OPRT Nasdaq
- Market Cap
- CMPX 291.8M
- OPRT 298.8M
- IPO Year
- CMPX N/A
- OPRT 2019
- Fundamental
- Price
- CMPX $2.97
- OPRT $6.05
- Analyst Decision
- CMPX Strong Buy
- OPRT Hold
- Analyst Count
- CMPX 8
- OPRT 2
- Target Price
- CMPX $13.50
- OPRT $8.00
- AVG Volume (30 Days)
- CMPX 1.3M
- OPRT 538.0K
- Earning Date
- CMPX 08-11-2025
- OPRT 08-06-2025
- Dividend Yield
- CMPX N/A
- OPRT N/A
- EPS Growth
- CMPX N/A
- OPRT N/A
- EPS
- CMPX N/A
- OPRT N/A
- Revenue
- CMPX N/A
- OPRT $724,757,000.00
- Revenue This Year
- CMPX N/A
- OPRT $28.27
- Revenue Next Year
- CMPX N/A
- OPRT $6.59
- P/E Ratio
- CMPX N/A
- OPRT N/A
- Revenue Growth
- CMPX N/A
- OPRT N/A
- 52 Week Low
- CMPX $1.15
- OPRT $2.37
- 52 Week High
- CMPX $4.08
- OPRT $9.25
- Technical
- Relative Strength Index (RSI)
- CMPX 50.84
- OPRT 45.10
- Support Level
- CMPX $2.66
- OPRT $5.66
- Resistance Level
- CMPX $3.47
- OPRT $6.32
- Average True Range (ATR)
- CMPX 0.25
- OPRT 0.33
- MACD
- CMPX -0.02
- OPRT 0.02
- Stochastic Oscillator
- CMPX 38.27
- OPRT 32.50
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.